FDA Clearance Tracker · P240003
Minima Stent System and Minima Pro Stent System
Last checked: Nov 20, 2026Latest source record: Aug 28, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Aug 28, 2024
Approved
Time to decision
180 days
Received Mar 1, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P240003
- Device name
- Minima Stent System and Minima Pro Stent System
- Applicant
- Renata Medical, Inc.
- Applicant location
- Newport Beach, CA
- Received
- Mar 1, 2024
- Decided
- Aug 28, 2024
- Decision
- Approved
- Supplements
- 8 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Aortic stent (PNF)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
The Minima Stent System is indicated for use in the treatment of native or acquired pulmonary artery stenoses or coarctation of the aorta in neonates, infants, and children at least 1.5 kg in weight.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code PNF. The earliest in FDA's data is P150028, decided Mar 25, 2016.
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
Other decisions for Renata Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.